![]() #LINKDOC TECHNOLOGY LTD REGISTRATION#This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by LinkDoc Technology Ltd. For financial reporting, their fiscal year ends on December 31st. The case examines how LinkDoc, specializing in big data and serving the vertical healthcare industry, found its own answers to these issues and, more specifically, how it identified and entered its target market segment, and subsequently found a way to commercialize its technology and create a viable business. LinkDoc Technology Ltd is primarely in the business of services-computer processing & data preparation. The issue, then, is how tech startups should strike a balance between "aiming too high" and "taking a faster route." The LinkDoc Technology (hereinafter "LinkDoc") case was compiled as one way to find answers to these questions. Others aim for low-hanging fruit in more easily accessible markets, at the expense of pursuing their original goal once engaged on this path, it is extremely difficult to change course and build an iconic name. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.This case examines a universal question: How can a tech startup (such as an AI or big data startup) address the pain points of traditional vertical industries through technological innovation and create value? Some tech startups set ambitious goals, which demand significant and sustained investments in R&D, but fail to plan for commercial development in order to remain viable: when funding runs out, they go bust. Female patients with T1a adenocarcinoma in the right upper lobe barely had lymph node metastasis.Ĭhinese patients T1 non-small cell lung cancer lymph node metastases real-world risk factors. This real-world study showed the significant association of lymph node metastasis with age, tumor size, histology and differentiation, carcinoembryonic antigen levels, and status of vascular invasion. The univariate and multivariate analyses showed that younger age, squamous cell carcinoma, poor differentiation, larger tumor size, carcinoembryonic antigen level ≥5 ng/mL, and vascular invasion (+) were significantly associated with higher percentages of lymph node metastases (P < 0.001 for all). Of the patients, 3260 (29.9%) were current or former smokers. Most patients had T1b lung cancer (4766, 43.8%). A total of 1159 patients (10.6%) had metastases in mediastinal nodes (N2), and 640 patients (5.9%) had metastasis in pulmonary lymph nodes (N1). The median age was 60.0 years (range 12.9-86.6 years). The clinical and pathological factors associated with lymph node metastasis were analyzed by univariate and multivariate logistic regression.Ī total of 10 885 participants (51.6% women 15.3% squamous cell carcinoma) were included in the analysis. Clinical and pathological information was collected with the assistance of the Large-scale Data Analysis Center of Cancer Precision Medicine-LinkDoc database. This is a multicenter retrospective analysis of pathological T1 non-small cell lung cancer patients who underwent surgical resection from 2 January 2014 to 27 December 2017. However, the clinical characteristics of patients with lymph node metastasis in China are not fully understood. 13 Medical Affairs, Linkdoc Technology Co, Ltd, Beijing, China.Īpproximately 8.3-15.9% of patients with clinical stage I non-small cell lung cancer are subsequently shown to have lymph node metastasis.12 Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China.11 Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China.10 Department of Thoracic Surgery, Henan Cancer Hospital, Zhengzhou, China.9 Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.8 Department of Thoracic Surgery, First Hospital Affiliated to Medical College of Zhejiang University, Hangzhou, China.7 Department of Thoracic Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.6 Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.5 Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.4 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai, China.3 Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. ![]() ![]() 2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China.1 Department of Thoracic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |